Cardiovascular Journal of Africa: Vol 29 No 5 (September/October 2018)

68 / 74

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 29, No 5, September/October 2018 330 AFRICA
parameters of body composition and muscle strength. Adv Exp Med
Biol 2015; 949: 49–56. doi: 10.1007/5584_2014_92.
101. Shiels MS, Katki HA, Freedman ND, Purdue MP, Wentzensen N,
Trabert B, et al. Cigarette smoking and variations in systemic immune
and inflammation markers. J Natl Cancer Inst 2004; 106(11): pii: dju294.
doi: 10.1093/jnci/dju294.
102. Tuttolomondo A, Maida C, Pinto A. Diabetic foot syndrome: Immune-
inflammatory features as possible cardiovascular markers in diabetes.
World J Orthop 2015; 6(1): 62–76. doi: 10.5312/wjo.v6.i1.62.
103. Tuttolomondo A, La Placa S, Di Raimondo D, Bellia C, Caruso A, Lo
Sasso B, et al . Adiponectin, resistin and IL-6 plasma levels in subjects
with diabetic foot and possible correlations with clinical variables and
cardiovascular co-morbidity. Cardiovasc Diabetol 2010; 9: 50. doi:
10.1186/1475-2840-9-50.
104. Tuttle HA, Davis-Gorman G, Goldman S, Copeland JG, McDonagh
PF. Proinflammatory cytokines are increased in type 2 diabetic women
with cardiovascular disease. J Diabetes Complications 2004; 18(6):
343–351. doi: 10.1016/S1056-8727(03)00088-6.
105. Misra DP, Das S, Sahu PK. Prevalence of inflammatory markers (high-
sesitivity C-reactive protein, nuclear factor-kB, and adiponectin) in
Indian patients with type 2 diabetes mellitus with and without macro-
vascular complications. Metab Syndr Relat Disord 2012; 10(3): 209–213.
doi: 10.1089/met.2011.0044.
106. Ridker PM, Danielson E, Fonseca F, Genest J, Gotto AM, Kastelein
JJP, et al. Rosuvastatin to prevent vascular events in men and women
with elevated C-reactive protein. N Engl J Med 2008; 359: 2195–2207.
doi: 10.1056/NEJMoa0807646.
107. Pop D, Dadarlat A, Zdrenghea D. Novel cardiovascular risk markers in
women with ischaemic heart disease. Cardiovasc J Afr 2014; 25: 137–141.
doi: 10.5830/CVJA-2014-014.
108. Pilote L, Dasgupta K, Guru V, Humphries KH, McGrath J, Norris C, et
al. A comprehensive view of sex-specific issues related to cardiovascular
disease. Can Med Assoc J 2007; 176: S1–S41. doi: 10.1503/cmaj.051455.
CardioVascular Journal of Africa (official journal for PASCAR)
Why you should publish with CVJA
• Increased international exposure (indexed in PubMed, Medline, PubMed Central,
Scopus, Embase and Thompson Reuters/ISI)
• Quick return on submissions
• Changing patterns of heart disease in Africa get more exposure than in other
journals
• Acceptance of diabetes studies as vascular studies in CVJA
• African studies are given preference
• Well-illustrated interventional studies are needed for CME in Africa
(full website support capability)
• Instructions for authors on
• A PowerPoint presentation for new authors: 'How to write a scientific paper'
• Submit your manuscript online at
Contact us on